Virtual Reality Versus Conventional Exercise Intradialysis

May 22, 2018 updated by: Eva Segura Ortí, Cardenal Herrera University

Comparison of Two Exercise Programs Intradialysis: Virtual Reality Exercise Versus Conventional Exercise

All participants exercised during 16 weeks following a conventional intradialysis exercise program. The last 4 weeks of the study participants were randomized into two different exercise programs intradialysis. One group exercised through a virtual reality exercise adapted specially for patients while receiving hemodialysis treatment. The other group exercised with a conventional exercise program, combining aerobic cycling and strengthening exercises.

Study Overview

Detailed Description

The first 16 weeks all participants followed an intradialysis exercise program. The exercise program consisted of strengthening exercises for lower limbs and for the upper limb free of fistula. The exercise program included isotonic exercises for quadriceps, triceps surae, psoas, glutei, and brachial biceps; and isometric exercises for hip adductors and hamstrings. Elastic bands were used to apply resistance. Progression was achieved from increasing from 1 set of 10 repetitions until 3 sets of 15 repetitions. This first part lasted no more than 30 minutes. The program also included aerobic exercise (cycling) for up to 30 minutes. Intensity was adapted through the duration of the study so that the participant felt the exercise from hard to somewhat hard (13 to 15 at the rate of perceived exertion 6 to 20). Time and resistance were adapted progressively.

The last four weeks of the program participants were randomized into virtual reality exercise or conventional exercise group. The virtual reality exercise group undertook 30 minutes of exercise. After warming up, participants had to play to an adapted 'treasure hunt' game. Their legs movements were the players projected into an individual tv that gave them feedback regarding their achievements. The aim of the game was to achieve the higher possible score.They moved to pick up coins and to avoid bombs. An adapted Kinect technology was used for the game development.

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Valencia
      • Manises, Valencia, Spain, 46940
        • Hospital de Manises

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

- Patients in HD therapy at least 3 months

Exclusion Criteria:

  • recent myocardial infarction (within 6 weeks)
  • unstable angina
  • malignant arrhythmias
  • above the knee amputation without replacement
  • cerebral vascular disease (ictus, transient ischemia)
  • musculoskeletal and respiratory disorders that can get worse with exercise
  • impossibility to achieve functional testing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtural reality exercise
Virtual reality exercise performed during the hemodialysis session, using the Kinect, specially adapted for patients undertaking hemodialysis
Game developed by the Kinect, adapted to the lying position of participants.
Active Comparator: Conventional exercise intradialysis
Exercise combining both aerobic (cycling) and strengthening exercise of lower limbs for patients during the hemodialysis session
Aerobic exercise (cycling) and strengthening exercise for lower limbs using elastic bands and gravity

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sit to Stand to Sit test 10
Time Frame: 20 weeks
Time required to stand up from a chair and sit down 10 consecutive times
20 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short Physical Performance Battery
Time Frame: 20 weeks
Balance, gait speed and sit to stand to sit 5 times
20 weeks
Timed Up and Go
Time Frame: 20 weeks
Time to stand up, walk a short distance, turn, walk back and sit down to the chair again
20 weeks
One leg stand test
Time Frame: 20 weeks
Time to keep balance on one leg
20 weeks
Sit to Stand to Sit test 60 seconds
Time Frame: 20 weeks
Number of repetitions achieved of standing up from a chair during 60 seconds
20 weeks
Handgrip
Time Frame: 20 weeks
Handgrip strength right and left hands
20 weeks
One leg heel rise test
Time Frame: 20 weeks
Number of repetitions of standing on toes in both legs
20 weeks
6 minutes walk test
Time Frame: 20 weeks
Number of meters covered during 6 minutes of walking
20 weeks
Adherence
Time Frame: 20 weeks
Sessions performed/offered
20 weeks
Physical Activity
Time Frame: 16 weeks
Human activity profile, adjusted and maximal activity score
16 weeks
Physical Activity
Time Frame: 16 weeks
Physical activity score for the elderly
16 weeks
Inflammatory markers
Time Frame: 16 weeks
Interleukin 6 (IL6)
16 weeks
Inflammatory markers
Time Frame: 16 weeks
Monocyte chemoattractant protein-1 (MCP-1)
16 weeks
Inflammatory markers
Time Frame: 16 weeks
C-Reactive Protein (CRP)
16 weeks
Inflammatory markers
Time Frame: 16 weeks
Human Tumor Necrosis Factor α (TNF-α)
16 weeks
Health-related quality of life
Time Frame: 16 weeks
SF-36 subscales and components
16 weeks
Oxidative stress markers
Time Frame: 16 weeks
Malondialdehyde (MDA)
16 weeks
Oxidative stress markers
Time Frame: 16 weeks
Carbonylated proteins
16 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Rafael García Maset, MD, Hospital de Manises

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2017

Primary Completion (Actual)

July 30, 2017

Study Completion (Actual)

August 31, 2017

Study Registration Dates

First Submitted

April 10, 2017

First Submitted That Met QC Criteria

April 15, 2017

First Posted (Actual)

April 19, 2017

Study Record Updates

Last Update Posted (Actual)

May 23, 2018

Last Update Submitted That Met QC Criteria

May 22, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on End Stage Renal Disease

Clinical Trials on Virtual Reality Exercise

3
Subscribe